Leuprolide Acetate 11.25Mg Injection

Leuprolide is used to treat endometriosis, uterine fibroids, prostate cancer, and central precocious puberty. It is also used in some IVF protocols. It works by suppressing oestrogen or testosterone production depending on the patient's condition.

Yes. Leuprolide Acetate 11.25 mg is the generic equivalent of Lupron Depot 11.25 mg by AbbVie (USA). In the UK, the equivalent branded product is Prostap SR 11.25 mg by Takeda. Both contain the same active ingredient and follow the same three-month dosing schedule.

One injection every 12 weeks (three months). It is administered by a healthcare professional as a subcutaneous or intramuscular depot injection, reducing clinic visits compared to monthly alternatives.

Yes. By lowering oestrogen levels, Leuprolide reduces fibroid volume and heavy bleeding. It is typically prescribed for three to six months as a pre-surgical measure to make removal easier, rather than as a long-term standalone treatment.

Yes, in certain IVF long protocols, Leuprolide suppresses natural hormone activity to allow controlled ovarian stimulation. The dose and timing used in IVF differ from the depot regimens used for endometriosis or prostate cancer.

Yes. Prostap SR 11.25 mg (Takeda, UK) contains leuprorelin acetate — the INN name for leuprolide acetate — at the same strength and for the same indications. It is the closest UK branded equivalent to Lupron Depot.

Common side effects include hot flushes, night sweats, reduced libido, mood changes, and injection site reactions. In men, it may cause erectile dysfunction and bone density loss over time. In women, symptoms can resemble menopause. Most effects resolve after treatment ends.

Both are GnRH agonists with similar mechanisms and outcomes. Goserelin (Zoladex) is more commonly used in the UK; Leuprolide is more common in the USA. Choice depends on local prescribing preference, formulation convenience, and patient tolerability.

Triptorelin (Decapeptyl, Diphereline) has comparable efficacy and is available in 1-month and 3-month depot forms. Leuprolide has more published data in prostate cancer and endometriosis; Triptorelin is more widely used across parts of Europe.

Leuprolide 11.25 mg is given once every 12 weeks as part of androgen deprivation therapy. It is used alone or combined with an antiandrogen such as bicalutamide for complete androgen blockade.